Clement Salque
Senior Associate at Bioqube Ventures | Brussels, Brussels Region, Belgium
Clement Salque’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
ContactOut Insights • AI Generated
Clement Salque serves as a Senior Associate at Bioqube Ventures, a global life sciences investment firm operating across Belgium and the United States. Based in Brussels within the pharmaceutical industry, he helps execute the company’s mandate to fund first- and best-in-class therapeutics targeting major unmet medical needs. Holding a degree from Université Paris Cité, Salque contributes to the firm’s strategy of building balanced venture portfolios and guiding early-stage biotechs through their initial clinical development phases.
BEST APPROACH TO REACH Clement Salque
With high directory confidence indicating reliable personal contact information, reach out via personal email with a concise proposal on how your pharmaceutical services streamline early clinical trial operations, and accompany the message with a tailored LinkedIn connection request to establish a direct professional line.
Board observer at SynOx Therapeutics in September 2024 - Present
Board observer at Actithera in July 2025 - Present
Senior Associate at Bioqube Ventures in June 2025 - Present
Université Paris Cité, July 2026
ESCP Business School, July 2026
China Europe International Business School (CEIBS), CEIBS China Virtual Program, July 2026
Bioqube Ventures is a global life sciences investment firm with offices in Belgium and the United States. The firm focuses on companies developing first- or best-in-class therapeutics to address major unmet medical needs. Bioqube builds balanced portfolios and supports companies from inception through early clinical milestones. For more information, please visit www.bioqubeventures.com Bioqube Ventures is dedicated to funding therapeutic innovations: - A life sciences venture capital fund – dedicated to advancing exciting science in European and US ecosystems to breakthrough therapies for patients. - A fit-for-purpose dual investment model – besides more classical investments in investment rounds, we have special attention for venture creation projects that require additional experiments prior to creating new ventures. With our in-house factory model we are able to translate exciting science into trailblazing companies. - A hands-on approach – the team is a mix of fund managers, sector experts and serial entrepreneurs that have a proven track record in successfully leading companies on their growth paths. We believe in putting our expertise at work where it matters.
Discover more about Bioqube VenturesPrincipal at Bioqube Ventures
Board Observer at Tridek-One
(Jul 2022 – Present)
Partner at Bioqube Ventures | Biotech Investor & Advisor
Scientific Advisor at Bootstrap Europe
(Dec 2020 – Present)
Cofounder and Managing Partner at Bioqube Ventures
Co-founder and Managing Partner at Bioqube Ventures
(Dec 2015 – Present)
Senior Director Charles River Labs & Operation Manager at Bioqube Ventures
Associate Director Hit to Lead and Lead Optimization, CRL Beerse Belgium
Responsibilities:
Overseeing screening campaigns and other discovery milestones.
Ensured rapid cycle of medchem compounds though profiling assays, maximizing opportunities for hit to lead progress.
Esta...
Partner at Bioqube Ventures
Board Member at Commit Biologics
(Jan 2022 – Present)
PhD Biomed | MSc AI
Life Science Investment, Analyst at Bioqube Ventures
(Apr 2025 – Present)
What is Clement Salque email address?
Email Clement Salque at [email protected] and [email protected]. This email is the most updated Clement Salque's email found in 2026.
How to contact Clement Salque?
To contact Clement Salque send an email to [email protected] or [email protected]. (updated on November 07, 2025)
What company does Clement Salque work for?
Clement Salque works for Bioqube Ventures.
What is Clement Salque's role at Bioqube Ventures?
Clement Salque is Senior Associate
What industry does Clement Salque work in?
Clement Salque works in the Pharmaceuticals industry.